115388-32-4

Basic information

• Product Name: NAN-190 HYDROBROMIDE
• Synonyms: NAN-190;NAN-190 HYDROBROMIDE;1-(2-METHOXYPHENYL)-4-(4-PHTHALIMIDOBUTYL)PIPERAZINE HYDROBROMIDE;1-(2-Methoxyphenyl)-4-(phthalimidobutyl)piperazine hydrobromide;1H-Isoindole-1,3(2H)-dione, 2-[4-[4-(2-Methoxyphenyl)-1-piperazinyl]butyl]-, hydrobroMide;2-(4-(4-(2-Methoxyphenyl)piperazin-1-yl)butyl)-isoindoline-1,3-dione hydrobromide
• CAS NO: 115388-32-4
• Molecular Formula: C23H28BrN3O3
• Molecular Weight: 474.39
• Product Categories: Serotonin receptor
• Mol File: 115388-32-4.mol
• Article Data: 0

Chemical Properties

• Boiling Point: 560.8°Cat760mmHg
• Flash Point: 293°C
• Appearance: /
• Density: g/cm³
• Vapor Pressure: 1.32E-12mmHg at 25°C
• Storage Temp.: Store at RT
• CAS DataBase Reference: NAN-190 HYDROBROMIDE(CAS DataBase Reference)
• NIST Chemistry Reference: NAN-190 HYDROBROMIDE(115388-32-4)
• EPA Substance Registry System: NAN-190 HYDROBROMIDE(115388-32-4)

Safety Data

• Hazardous Substances Data: 115388-32-4(Hazardous Substances Data)

Usage

Description

NAN-190 HYDROBROMIDE is an N-alkylpiperazine compound that features a (2-methoxyphenyl)piperazine structure with the amine hydrogen replaced by a 4-(2-phthalimido)butyl group. It is a pharmaceutical compound with potential applications in various fields.

Uses

Used in Pharmaceutical Industry:
NAN-190 HYDROBROMIDE is used as a research chemical for the development of medications targeting specific receptors in the central nervous system. Its unique structure allows it to interact with these receptors, potentially leading to the creation of new therapeutic agents for various conditions.
Used in Research Applications:
In the field of scientific research, NAN-190 HYDROBROMIDE serves as a valuable tool for studying the effects of N-alkylpiperazine compounds on biological systems. It can be used to investigate receptor binding, signal transduction pathways, and the overall impact on cellular function.
Used in Drug Development:
NAN-190 HYDROBROMIDE is utilized in the process of drug development to identify potential lead compounds with therapeutic properties. Its unique chemical structure makes it a candidate for further optimization and modification to enhance its efficacy and safety profile in treating specific diseases.

Biological Activity

5-HT 1A antagonist.

InChI:InChI=1/C23H27N3O3/c1-29-21-11-5-4-10-20(21)25-16-14-24(15-17-25)12-6-7-13-26-22(27)18-8-2-3-9-19(18)23(26)28/h2-5,8-11H,6-7,12-17H2,1H3/p+1